China Development Industrial Bank (CDIB) logo

China Development Industrial Bank (CDIB)

Asia, T'ai-pei, Taiwan, Taipei

Description

CDIB, originally China Development Industrial Bank, has evolved significantly from its roots as a development bank and early-stage venture capital investor in Taiwan. Established in 1959, the institution played a pivotal role in fostering Taiwan's industrial and technological growth. In 2005, its direct investment business spun off to form CDIB Capital Group, which has since transformed into a prominent private equity firm. While the group acknowledges a long track record of investing across various stages, including early-stage venture capital, its current primary focus is on growth capital and buyouts across Greater China and Asia.

CDIB Capital Group manages substantial assets, with over US$2.6 billion under management as of recent reports. The firm has a robust history of deploying capital, having invested over US$2.5 billion across more than 100 companies since its inception. Its investment strategy spans critical sectors such as TMT (Technology, Media, and Telecommunications), healthcare, consumer, advanced manufacturing, new materials, and clean energy. The group's latest flagship fund, CDIB Capital Asia Partners IV, successfully closed at US$1.05 billion in 2023, underscoring its capacity for large-scale investments.

For its typical private equity transactions, CDIB Capital Group generally invests between US$10 million and US$50 million per deal. While its historical venture capital activities were instrumental in its early days, the firm's current operational model and fund structures are geared towards larger growth equity and buyout opportunities. This strategic shift allows CDIB Capital Group to support established companies seeking expansion capital or facilitate ownership changes, leveraging its extensive network and deep industry expertise across the Asian markets.

Investor Profile

China Development Industrial Bank (CDIB) has backed more than 52 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 12% of its total and boasts 31 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Taiwan, Israel.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Typical check size: $10M – $50M.

Stage Focus

  • Series B (31%)
  • Series Unknown (21%)
  • Series C (17%)
  • Series D (13%)
  • Series A (10%)
  • Private Equity (4%)
  • Post Ipo Equity (2%)
  • Series E (2%)

Country Focus

  • United States (88%)
  • Taiwan (8%)
  • Israel (2%)
  • China (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Semiconductor
  • Security
  • Biopharma
  • Software
  • Enterprise Software
  • Wireless
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Development Industrial Bank (CDIB) frequently co-invest with?

IC
North America, California, United States, Palo Alto
Co-Investments: 3
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 5
United Investments
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 5
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 4
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 6
Trellis Partners
North America, Texas, United States, Cedar Creek
Co-Investments: 3
Lucent Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 4
PC
North America, Utah, United States, Orem
Co-Investments: 3
Venrock
North America, California, United States, Palo Alto
Co-Investments: 7
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 4

Which angels does China Development Industrial Bank (CDIB) often collaborate with?

Allen Chao
Asia, T'ai-pei, Taiwan
Shared Deals: 1

What are some of recent deals done by China Development Industrial Bank (CDIB)?

Eden Biologics

Hsinchu, T'ai-wan, Taiwan

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical
Post Ipo EquityMay 29, 2018
Amount Raised: $106,000,000
Viscovery

Taipei, T'ai-pei, Taiwan

Viscovery is a vision artificial intelligence company based on deep learning and computer vision technology.

Artificial Intelligence (AI)Computer VisionE-CommerceInformation TechnologyMachine LearningRetail TechnologySoftwareVideo
Series UnknownOct 18, 2016
Amount Raised: $10,000,000
WeDoctor

Xiaoshan, Zhejiang, China

WeDoctor is a medical health technology platform that offers online services for hospitals and doctors on-site.

Health CareHospitalityInternetMedical
Series CSep 24, 2015
Amount Raised: $394,000,000
Eden Biologics

Hsinchu, T'ai-wan, Taiwan

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical
Series BJun 19, 2014
Amount Raised: $35,000,000
Apexigen

San Carlos, California, United States

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

BiopharmaBiotechnologyHealth CareOncologyPharmaceutical
Series AAug 6, 2013
Amount Raised: $20,000,000
Optimer Pharmaceuticals

San Diego, California, United States

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DDec 14, 2005
Amount Raised: $22,200,000
Light Sciences Oncology

Bellevue, Washington, United States

Light Sciences Oncology develops light-activated drug products to treat patients with solid tumor cancers.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series ADec 14, 2005
Amount Raised: $32,000,000
Light Sciences Oncology

Bellevue, Washington, United States

Light Sciences Oncology develops light-activated drug products to treat patients with solid tumor cancers.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series AOct 11, 2005
Amount Raised: $35,000,000
Pixim

Mountain View, California, United States

Pixim is a semiconductor company that manufactures chips for video cameras.

Enterprise SoftwareHardwareVideo
Series UnknownJun 9, 2005
Amount Raised: $12,000,000
CipherMax

San Jose, California, United States

CipherMax provides storage security solutions for information assets and achieving compliance with government regulations.

ComplianceGovernmentSecurity
Series DDec 13, 2004
Amount Raised: $29,000,000